Position in AMLX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$12,554,366
+$3,237,692 QoQ
Shares Held
903,192
+17.1% QoQ
Ownership
0.812%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 88%
Shared 10%
None 2%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $3,107,808,414 across 44 Drug Manufacturers - Specialty & Generic names. AMLX ranks #27 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
24,527,135 | $586,934,337 | |
| 2 | VTRS |
Viatris Inc
|
38,310,693 | $517,577,461 | |
| 3 | ZTS |
Zoetis Inc.
|
2,771,447 | $327,612,748 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
512,739 | $304,043,970 | |
| 5 | ALKS |
Alkermes plc.
|
4,522,378 | $159,911,284 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
2,672,777 | $158,415,490 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
2,307,030 | $119,250,378 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,379,570 | $104,640,383 |
All Filings in AMLX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,554,366 | 903,192 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $9,316,674 | 771,248 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,927,908 | 509,780 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,395,666 | 373,739 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $437,457 | 123,576 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $204,550 | 54,114 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||